Comment on "a comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes"

被引：7
|
作者：
Freemantle, Nick [1 ]
Jourdan, Sophie [2 ]
机构：
[1] UCL, Inst Clin Trials & Methodol, 90 High Holborn 2nd Floor, London WC1V 6LJ, England
[2] Sanofi, Hlth Econ & Value Assessment, Paris, France
来源：
DIABETES OBESITY & METABOLISM | 2019年 / 21卷 / 07期
关键词：
D O I：
10.1111/dom.13711
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1758 / 1759
页数：2
相关论文
共 50 条
  • [1] A comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes
    Tibaldi, Joseph
    Hadley-Brown, Martin
    Liebl, Andreas
    Haldrup, Steffen
    Sandberg, Viktor
    Wolden, Michael L.
    Rodbard, Helena W.
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 1001 - 1009
  • [2] CONFIRM: a comparative effectiveness study of insulin degludec and insulin glargine 300 units/ ml (glargine U300) in insulin-naive patients with type 2 diabetes
    Tibaldi, J.
    Haldrup, S.
    Sandberg, V.
    Wolden, M. L.
    Rodbard, H. W.
    DIABETOLOGIA, 2018, 61 : S44 - S44
  • [3] Comparative effectiveness of insulin glargine 300 U/mL and insulin degludec 100 U/mL in insulin naive type 2 diabetes adults: the Restore-2 naive cohort
    Fadini, G. P.
    Buzzetti, R.
    Larosa, M.
    Rossi, M. C.
    Nicolucci, A.
    Cucinotta, D.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 74 - 74
  • [4] Clinical Outcome Assessment of the Effectiveness of Insulin Degludec (Degludec) in Real-life Medical Practice (CONFIRM)-A Comparative Effectiveness Study of Degludec and Insulin Glargine 300U/mL (Glargine U300) in Insulin-Naive Patients with Type 2 Diabetes (T2D)
    Tibaldi, Joseph
    Haldrup, Steffen
    Sandberg, Viktor
    Wolden, Michael L.
    Rodbard, Helena W.
    DIABETES, 2018, 67
  • [5] Lower hypoglycaemia rates with insulin glargine 300 U/ml vs insulin degludec 100 U/ml in insulin-naive adults with type 2 diabetes: the BRIGHT randomised trial
    Bolli, G. B.
    Cheng, A.
    Bosnyak, Z.
    Boelle-Le Corfec, E.
    Cali, A. M. G.
    Wang, X.
    Frias, J.
    Roussel, R.
    Rosenstock, J.
    DIABETOLOGIA, 2018, 61 : S442 - S442
  • [6] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study
    Galstyan, Gagik R.
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen
    Coudert, Mathieu
    Naqvi, Mubarak
    Pilorget, Valerie
    Khan, Niaz
    DIABETES THERAPY, 2022, 13 (06) : 1187 - 1202
  • [7] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [8] Lower hypoglycemia rates with Glargine 300 U/mL vs. insulin Degludec 100 U/mL in insulin-naive adults with type 2 diabetes - The BRIGHT Randomized Study
    Bolli, Geremia
    Scherer, Thomas
    Cheng, Alice
    Bosnyak, Zsolt
    Boelle-Le Corfec, Emmanuelle
    Cali, Anna
    Wang, Xiangling
    Frias, Juan
    Roussel, Ronan
    Rosenstock, Julio
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 369 - 369
  • [9] Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naive patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)
    Fadini, Gian Paolo
    Buzzetti, Raffaella
    Nicolucci, Antonio
    Larosa, Monica
    Rossi, Maria Chiara
    Cucinotta, Domenico
    ACTA DIABETOLOGICA, 2022, 59 (10) : 1317 - 1330
  • [10] Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naive type 2 diabetes: Design and population
    Bonadonna, R. C.
    Giaccari, A.
    Buzzetti, R.
    Aimaretti, G.
    Cucinotta, D.
    Avogaro, A.
    Perseghin, G.
    Larosa, M.
    Bolli, G. B.
    Fanelli, C. G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (05) : 496 - 503
12345